⌘K

Login Start Free

Home/Filings/4/0001628280-22-018607

4//SEC Filing

White Lale 4

Accession 0001628280-22-018607

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:10 PM ET

Size

6.8 KB

Accession

0001628280-22-018607

Insider Transaction Report

Form 4

Period: 2022-07-05

Cardiff Oncology, Inc.CRDF

Director

Transactions

Exercise/Conversion
Common Stock
2022-07-05$2.60/sh+28,858$75,031→ 98,788 total(indirect: By Trust)
Exercise/Conversion
Stock Options
2022-07-05$2.60/sh−28,858$75,031→ 60,716 total
Exercise: $2.60From: 2021-06-17Exp: 2030-06-17→ Common Stock (28,858 underlying)

Documents

1 file

4
wf-form4_165713821643094.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001635493

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 4:10 PM ET
Size: 6.8 KB

View on SEC.gov